RecallDepth
Class III Ongoing

Eptifibatide injection 20mg/10mL (2mg/mL), 10mL Single-Dose Vial, Rx only, Mfd. In India for: AuroMedics Pharma, LLC, E. Windsor, NJ 08520, NDC 55150-219-10

This recall is currently active, issued June 26, 2024. It was issued by Eugia Us Llc.

Company
Eugia Us Llc
Recall Initiated
May 22, 2024
Posted
June 26, 2024
Recall Number
D-0556-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
15,500 single dose vials
Firm Location
East Windsor, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Impurities/Degradation Specifications: failed related substance identified as Eptifibatide dimer.

Distribution

USA nationwide.

Lot / Code Info

Lot #: 3EF22003, Exp 6/30/2025

More recalls by Eugia Us Llc

View all recalls by this company →

Other recent Class III Drug recalls